Evodosin A shows potential in anti-inflammatory applications, particularly in modulating immune responses associated with chronic inflammatory conditions. It has demonstrated inhibitory effects on key signaling pathways such as NF-κB, which plays a central role in inflammation and cell survival. Due to this activity, Evodosin A is being explored for use in developing therapeutics for autoimmune diseases and inflammatory skin disorders. Additionally, preliminary studies suggest it may possess antiviral properties, especially against certain enveloped viruses, by interfering with viral entry into host cells. Its natural origin and specific mechanism of action make it a candidate for further development in pharmaceuticals targeting inflammation and viral infections.